Navigation Links
Schedules Revised for Flu, Meningitis Vaccines
Date:1/11/2008

Goal is to make it easier for parents to protect their children, CDC says

FRIDAY, Jan. 11 (HealthDay News) -- Expanded use of the FluMist vaccine for children and revised meningococcal vaccination guidelines for teens are part of new immunization recommendations released Friday.

The 2008 Childhood and Adolescent Immunization Schedules were released jointly by the U.S. Centers for Disease Control and Prevention, the American Academy of Pediatrics, and the American Academy of Family Physicians.

"Although we can now protect more children against more vaccine-preventable diseases than ever before, the immunization schedules can be confusing for parents and physicians," Dr. Anne Schuchat, director of the CDC's National Center for Immunization and Respiratory Diseases, said in a prepared statement. "The updates to this year's schedule help clarify our vaccination recommendations and, therefore, should make it easier for parents to protect their children against potentially serious diseases."

The childhood schedule changes to expand the recommendation for the nasal spray flu vaccine, FluMist, to now include children from 2 to 4 years of age without a history of asthma or wheezing. The vaccine, which contains a weakened form of the live virus and is sprayed in the nose, had previously been limited to healthy children 5 years of age and older and healthy adults up to age 50.

"We know that vaccinating children protects them against flu," Schuchat said. "This recommendation gives parents another choice when vaccinating their children."

The updated immunization schedule also includes vaccination against meningococcal disease, or meningitis. The Meningococcal Conjugate Vaccine (MCV4) is now recommended for children 11 to 12 years of age and teens 13 to 18 years of age who haven't been previously vaccinated and other people at heightened risk of meningococcal disease, including college freshmen living in dorms, as well as military recruits, the statement said.

Schuchat said the meningococcal disease recommendation modifies and simplifies the previous recommendation for routine vaccination with MCV4 of children 11 to 12 years of age, teens before starting high school (approximately 15 years of age), and other people at increased risk.

"Our goal is routine vaccination of all children beginning at age 11 years. College freshmen living in dormitories are at increased risk of meningococcal disease and should be vaccinated with MCV4 before college entry, if not previously," Schuchat said.

The new schedule also clarifies and updates recommendations for use of pneumococcal vaccine, which protects against pneumonia. Healthy children 24 months through 59 months of age not completely vaccinated should receive one dose of pneumococcal conjugate vaccine (PCV4). Children 2 year of age and older with underlying medical conditions should receive pneumococcal polysaccharide vaccine (PPV), the statement said.

More information

For more on vaccine-preventable childhood diseases, visit the CDC.



-- HealthDay staff



SOURCE: U.S. Centers for Disease Control and Prevention, Atlanta, news release, Jan. 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Echo Healthcare Reschedules Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 21, 2007
2. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
3. The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007
4. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
5. GNC Schedules Conference Call and Webcast to Report Third Quarter 2007 Financial Results
6. Thoratec Schedules Third Quarter Conference Call, Webcast
7. MSA Schedules Third Quarter Earnings Webcast
8. WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007
9. Cardiac Science Corporation Schedules Third Quarter Earnings Release and Announces Conference Call
10. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
11. AMICAS Schedules Third Quarter Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Schedules Revised for Flu, Meningitis Vaccines
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology: